Dr. Hutchinson’s Trip To India

As many of you are aware, I was asked to go to India with a team of international headache experts to educate local providers. Each one of us on the team had a specific purpose and for me, it was to focus on the treatment of migraine in women. The need for good migraine management in India is great. With a population of over 1.3 billion, the estimated prevalence of migraine in India is over 150,000 million. By comparison, the prevalence of migraine in the United States is 38 million.

2019-04-01T20:51:50+00:00April 1st, 2019|News|

Ajovy Webcast Summary

Dr. Susan Hutchinson joined Dr. Jack Schim for a live Webcast on Thursday evening, October 25th, to discuss Ajovy, the second CGRP monoclonal Antibody approved for migraine prevention. It is an injection and offers the option of quarterly or monthly dosing.

2018-11-01T17:05:21+00:00November 1st, 2018|News|

Dr. Hutchinson 2nd Author On An Abstract Titled “Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study”

Dr. Hutchinson was 2nd author on an abstract titled "Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study" that was accepted as a poster presentation both at the recent American Headache Society Scientific Symposium in June 2018 and at the Diamond Headache Clinic Research & Educational Foundation in July 2018.

2018-07-16T21:04:18+00:00July 16th, 2018|News|

Annual John Graham Lecture Award Winner Thanks Dr. Hutchinson Among Others

Professor Gretchen Tietjen recently received the annual John Graham lecture award from Paul Rizzoli and thanked friends and collaborators including Lynne Osborn Geweke, Dawn Buse, Sheena K. Aurora and Susan Lynn Hutchinson. "I am so happy for Dr. Gretchen Tietjen to receive this prestigious award. I was happy to be part of our Women's Issues [...]

2017-06-14T18:32:23+00:00June 14th, 2017|News|
Go to Top